Home > Insider Trading > Filing (0001077183-21-000260)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1077183	Neogenomics Inc	NEO	Services-Testing Laboratories (8734)	742897368

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1720001	B Kathryn Mckenzie	9490 Neogenomics Way Fort Myers FL 33912	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-12-21	1,846	$35.00	11,689	No	4	S	Direct
Common Stock	Acquisiton	2021-12-22	5,000	$9.07	16,689	No	4	M	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	M	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2021-12-22	5,000	$0.00	5,000	$9.07

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
20,000		2022-10-18	No	4	M	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (Right to Buy)	$8.03	2023-02-26	40,000	40,000	Direct
Common Stock	Stock Option (Right to Buy)	$19.60	2024-03-01	13,894	13,894	Direct
Common Stock	Stock Option (Right to Buy)	$28.33	2027-03-02	37,514	37,514	Direct
Common Stock	Stock Option (Right to Buy)	$53.17	2028-03-02	35,171	35,171	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2023-02-26	40,000	40,000	Direct
2024-03-01	13,894	13,894	Direct
2027-03-02	37,514	37,514	Direct
2028-03-02	35,171	35,171	Direct

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
On October 17, 2017, Ms. McKenzie was granted 25,000 stock options. These options vested ratably over the first three anniversary dates of the grant date
On February 26, 2018, Ms. McKenzie was granted 48,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
On March 1, 2019, Ms. McKenzie was granted 13,894 stock options. These options vest ratably over the first four anniversary dates of the grant date.
On March 2, 2020, Ms. McKenzie was granted 37,514 stock options. These options vest ratably over the first four anniversary dates of the grant date.
On March 2, 2021, Ms. McKenzie was granted 35,171 stock options. These options vest ratably over the first four anniversary dates of the grant date.